SJC PGY1 '23
UofSC COP '22
UofSC '17
Twice-a-year s.c. Lenacapavir prevents nearly all new HIV infections, superior to oral PrEP.
Biggest challenge: to make this incredibly effective prevention available to the most vulnerable populations & in regions with highest HIV transmission. #PURPOSE2
Twice-a-year s.c. Lenacapavir prevents nearly all new HIV infections, superior to oral PrEP.
Biggest challenge: to make this incredibly effective prevention available to the most vulnerable populations & in regions with highest HIV transmission. #PURPOSE2